Skip to Content

What drugs are contained in Trelegy Ellipta?

Answers (1)

Official Answer by 7 Nov 2017

Trelegy Ellipta is a dry powder inhalation agent that contains fluticasone furoate, umeclidinium, and vilanterol. Trelegy Ellipta is approved for the treatment of patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

It combines a unique triple therapy; a corticosteroid (fluticasone) with an anticholinergic agent (umeclidinium) and a long-acting beta-2 agonist (vilanterol). It is used for either those on a fixed-dose combination of fluticasone/vilanterol (Breo Ellipta) who need added bronchodilation, or those who are already using Breo Ellipta and Incruse Ellipta (umeclidinium). free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What disease is Elzonris (tagraxofusp-erzs) used to treat?

Updated 7 Jan 2019 1 answerFAQ by

How do you use the ProAir Digihaler?

Updated 7 Jan 2019 1 answerFAQ by

How many biosimilars have been approved in the United States?

Updated 8 Jan 2019 1 answerFAQ by

What are the brands of sumatriptan?

Updated 5 Feb 2019 1 answerFAQ by

What is botulinum toxin used to treat?

Updated 14 Feb 2019 1 answerFAQ by